التفاصيل البيبلوغرافية
| العنوان: |
Dornase Alfa as Postoperative Therapy in Cystic Fibrosis Sinonasal Disease. |
| المؤلفون: |
Cimmino, Mariano, Nardone, Massimiliano, Cavaliere, Matteo, Plantulli, Angela, Sepe, Angela, Esposito, Valeria, Mazzarella, Giuseppina, Raia, Valeria |
| المصدر: |
Archives of Otolaryngology - Head & Neck Surgery; Dec2005, Vol. 131 Issue 12, p1097-1101, 5p, 2 Charts, 1 Graph |
| مصطلحات موضوعية: |
CYSTIC fibrosis, GENETIC disorders, GENETICS, GENETIC disorder diagnosis, SINUSITIS, PARANASAL sinus diseases |
| مستخلص: |
Objective To determine the benefit of nasally inhaled dornase alfa in patients with cystic fibrosis and nasal symptoms. Design Double-blind placebo-controlled trial. Setting Cystic Fibrosis Regional Center of Campania at the University of Naples “Federico II.” Patients A total of 24 patients with cystic fibrosis and chronic sinusitis. Interventions Patients underwent sinonasal surgery during a 3-year period and received once-daily doses of either dornase alfa (2.5 mg) or hypotonic saline solution (5 mL) beginning 1 month after surgery and for a 12-month period. Main Outcome Measures Primary outcomes were nasal-related symptoms and nasal endoscopic appearance; secondary outcomes were forced expiratory volume in 1 second, nasal computed tomography findings, and saccharine clearance test results. Patients were evaluated before and after treatment. Results After surgery, all outcomes were significantly improved for each treatment at 1 month (P<.05); primary outcomes were improved at 24 and 48 weeks in the group receiving dornase alfa (P<.05), and at 12 weeks in the group receiving placebo. Secondary outcomes were better in the dornase alfa group (P<.01) than in the placebo group at 12 months except for the saccharine clearance test results. In particular, median relative difference in forced expiratory volume in 1 second between dornase alfa and placebo was significantly improved in the dornase alfa group (P<.01). Conclusions Nasally inhaled dornase alfa can be effective in patients with cystic fibrosis and sinonasal disease who do not respond to conventional therapy after surgical treatment. Further studies should be carried out to determine the long-term effect on sinus disease, recurrence of polyps, and quality of life. [ABSTRACT FROM AUTHOR] |
|
Copyright of Archives of Otolaryngology - Head & Neck Surgery is the property of American Medical Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
